Dahn HM, Boersma LJ, De Ruysscher D, Meattini I, Offersen BV, Pignol J-P, Aristei C, Belkacemi Y, Benjamin D, Bese N (2021) The use of bolus in postmastectomy radiation therapy for breast cancer: A systematic review. Critical Reviews in Oncology/Hematology 163:103391
Jatoi A, Ellison N, Burch PA, Sloan JA, Dakhil SR, Novotny P, Tan W, Fitch TR, Rowland KM, Young CY (2003) A phase II trial of green tea in the treatment of patients with androgen independent metastatic prostate carcinoma. Cancer: Interdisciplinary International Journal of the American Cancer Society 97:1442–1446
Krug D, Baumann R, Krockenberger K, Vonthein R, Schreiber A, Boicev A, Würschmidt F, Weinstrauch E, Eilf K, Andreas P (2021) Adjuvant hypofractionated radiotherapy with simultaneous integrated boost after breast-conserving surgery: results of a prospective trial. Strahlentherapie und Onkologie 197:48–55
Thomas F, Holly JM, Persad R, Bahl A, Perks CM (2011) Green tea extract (epigallocatechin-3-gallate) reduces efficacy of radiotherapy on prostate cancer cells. Urology 78:475-e15
Xie Y, Wang Q, Hu T, Chen R, Wang J, Chang H, Cheng J (2021) Risk Factors Related to Acute Radiation Dermatitis in Breast Cancer Patients After Radiotherapy: A Systematic Review and Meta-Analysis. Frontiers in oncology 11
Zhao H, Zhu W, Jia L, Sun X, Chen G, Zhao X, Li X, Meng X, Kong L, Xing L (2016) Phase I study of topical epigallocatechin-3-gallate (EGCG) in patients with breast cancer receiving adjuvant radiotherapy. The British Journal of Radiology 89:20150665
Zhu W, Jia L, Chen G, Zhao H, Sun X, Meng X, Zhao X, Xing L, Yu J, Zheng M (2016) Epigallocatechin-3-gallate ameliorates radiation-induced acute skin damage in breast cancer patients undergoing adjuvant radiotherapy. Oncotarget 7:48607